Veppanu Tablet
Product Images NDC 84043-200

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Veppanu (NDC 84043-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arvinas Operations, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Description: This is a Kaplan-Meier plot showing the progression-free survival based on BICR assessment in VERITAC-2 for patients with ESR1-mutated tumors. The plot compares the effectiveness of two treatments, "VEPPANU" and "Fulvestrant", over a duration of time measured in months. The number of patients at risk are shown below the graph for each time point.*
FDA Label Image

Vep100 (Veppanu 100mg)

FDA Label Image

Vepp200 (Veppanu 200mg)

FDA Label Image

Chemstructure (Chemstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.